Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Other Working Capital Changes: 2020-2024

Historic Other Working Capital Changes for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $156,987.

  • Cardiol Therapeutics' Other Working Capital Changes rose 127.07% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $156,987 for FY2024, which is 61.24% down from last year.
  • Per Cardiol Therapeutics' latest filing, its Other Working Capital Changes stood at $156,987 for FY2024, which was down 61.24% from $405,026 recorded in FY2023.
  • Cardiol Therapeutics' 5-year Other Working Capital Changes high stood at $1.0 million for FY2022, and its period low was -$1.7 million during FY2021.
  • Its 3-year average for Other Working Capital Changes is $532,508, with a median of $405,026 in 2023.
  • As far as peak fluctuations go, Cardiol Therapeutics' Other Working Capital Changes slumped by 3,478.64% in 2021, and later skyrocketed by 160.43% in 2022.
  • Yearly analysis of 5 years shows Cardiol Therapeutics' Other Working Capital Changes stood at -$47,881 in 2020, then plummeted by 3,478.64% to -$1.7 million in 2021, then spiked by 160.43% to $1.0 million in 2022, then tumbled by 60.89% to $405,026 in 2023, then slumped by 61.24% to $156,987 in 2024.